Aurobindo moves to dismiss Walmart's US antitrust claims over generic drugs
MLex Summary: Aurobindo moved to dismiss Walmart's US antitrust claims over its supposed involvement in a conspiracy to fix the prices of generic drugs, arguing that the retailer's amended complaint repeats...To view the full article, register now.
Already a subscriber? Click here to view full article